U.S. Contraceptives Drugs And Devices Market Size 2019 Key Strategies by (Teva Pharmaceutical, Church & Dwight, Reckitt Benckiser, Cipla Limited, Merck & Co) Industry more than at 5.6% CAGR by 2024

U.S. Contraceptives Drugs And Devices Market 2019-2024: Contraceptives are birth spacing products that aid in avoiding unplanned pregnancy. There are five widely used contraceptive methods, namely sterilization, hormonal method, barrier method, emergency contraception, and intrauterine method. Sterilization is the most common method implemented globally. While there are a plethora of female contraceptives available in the market, companies and a few University researchers are trying to introduce male contraceptive methods. Women contraceptive methods include vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid 60% of maternal deaths and 57% of child deaths worldwide, as opined by the World Health Organization (WHO) in 2014. Therefore, various family planning initiatives have been introduced by governmental and non-governmental agencies in order to create awareness about prevention of unplanned pregnancy.

The global U.S. contraceptive drugs and devices market was valued at US$ 6,785.9 million in 2016 and is all set to rise at a CAGR of 5.6% during the forecast period (2016 – 2024)

Get a Quick Sample PDF Brochure at https://decisionmarketreports.com/request-sample?productID=981665

Key features of the study:

• This report provides in-depth analysis of the U.S. contraceptives drugs and devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the U.S. contraceptives drugs and devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Reckitt Benckiser Plc, Pfizer, Inc., Bayer AG, Mayer Laboratories, Inc., The Female Health Company, Cooper Surgical, Inc., Allergan plc, Cipla Limited, and Merck & Co. Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, market expansion, and marketing tactics
• The U.S. contraceptives drugs and devices market report caters to various stakeholders in this industry, including investors, drug and device manufacturers, distributors and suppliers for contraceptives drugs and devices, government organizations, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the contraceptives drugs and devices market would provide stakeholders vital inputs to make strategic decisions accordingly

This report segments the U.S. contraceptives drugs and devices market on the basis of product type and geography. On the basis of product type, the U.S. contraceptives drugs and devices market is segmented into drug and devices. Drugs are further sub-segmented into oral pills, injectables, and topical contraceptives. The contraceptive devices segment is further sub-segmented into male contraceptives devices and female contraceptives devices. Female contraceptives devices include female condoms, contraceptive diaphragms, contraceptive sponges, and contraceptive vaginal rings. Intrauterine devices, and subdermal contraceptive implants.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/981665/u-s-contraceptives-drugs-and-devices-market

Companies present in the contraceptives market prefer marketing oral contraceptive pills to churn out considerable and constant revenues compared to one-time revenue generated through long-acting contraceptives. Moreover, there is heavy promotion of oral pills compared to the long acting contraceptives such as IUD, and implant. This has kept the consumers away from the real benefits of long acting contraceptives over the oral pills. This is the reason that oral pills dominate the U.S. contraceptive drugs and devices market. The oral pills market is projected to experience the entry of generics with patent expirations nearing in the forecast period.

However, demand for advanced contraceptive options such as IUD, injectables, implants and diaphragms is observed to be high globally. This is owing to growing awareness among the populace, availability of reimbursement and growing demand for long term contraceptive methods. Government promotes the use of IUD and implants i.e. long-acting contraceptives for better therapeutic effect and safety. Also, reimbursement schemes are made attractive for consumers to opt for these contraceptive methods.

Detailed Segmentation:
• U.S. Contraceptives Drugs And Devices Market, By Product Type:
o Contraceptive Drugs
 Oral Contraceptive Pills
 Contraceptive Injectables
 Topical Contraceptives

o Contraceptive Devices
 Male Contraceptive Devices
 Condoms
 Female Contraceptive Devices
 Female Condoms
 Contraceptive Diaphragms
 Contraceptive Sponges
 Contraceptive Vaginal Rings
 Intrauterine Devices
 Hormonal
 Copper-T
 Subdermal Contraceptive Implants

• Company Profiles
o Teva Pharmaceutical Industries Ltd.*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans

o Church & Dwight Co. Inc.
o Reckitt Benckiser Plc
o Pfizer, Inc.
o Bayer AG
o Mayer Laboratories, Inc.
o The Female Health Company
o Cooper Surgical, Inc.
o Allergan Plc
o Cipla Limited
o Merck & Co. Inc.

For Better Insights help@decisionmarketreports.com

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet By Product Type
 Market Trends
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Mergers and Acquisitions
o Technology Overview
o Promotion Initiatives/Campaigns
o Reimbursement Scenario
o Pipeline Analysis

4. U.S. Contraceptive Drugs and Devices Market, By Product Type, 2014 - 2024 (US$ Million)
o Introduction
 Market Share Analysis, 2015 and 2024 (%)
 Y-O-Y Growth Analysis, 2014 - 2024
 Segment Trends
o Drugs
 Introduction
 Market Share Analysis, 2015 and 2024 (%)
 Y-O-Y Growth Analysis, 2014 - 2024
 Segment Trends
 Oral Contraceptive Pills
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Contraceptive Injectables
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Topical Contraceptives
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Devices
 Introduction
 Market Share Analysis, 2015 and 2024 (%)
 Y-O-Y Growth Analysis, 2014 - 2024
 Segment Trends
 Male Devices
 Condoms
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Female Devices
 Condoms
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Contraceptive Diaphragms
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Contraceptive Sponges
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Contraceptive Vaginal Rings
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
 Intrauterine Devices
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
1. Hormonal
2. Copper-T
 Subdermal Contraceptive Implants
 Introduction
 Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)

Browse Complete Report with Table of Content at https://decisionmarketreports.com/request-sample?productID=981665

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.